NCT06135233

Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:

Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe: A Critical Appraisal of the First 3 Years of the E-MIPS Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,336 (actual)
• Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Detailed description

The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe. International multicenter audit-based studies focusing on outcomes of minimally invasive pancreatoduodenectomy (MIPD) are lacking. A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Conditions

• Pancreas Disease

Interventions

Type	Name	Description
OTHER	No intervention	all patients undergoing minimally invasive pancreatic surgery, no intervention, no randomization

Timeline

• Start date: 2019-01-01
• Primary completion: 2021-12-31
• Completion: 2022-01-01
• First posted: 2023-11-18
• Last updated: 2023-11-18

Locations

1 site across 1 country: Netherlands